Hypotensive effectof chronically infused adrenomedullin in conscious Wistar-Kyoto and spontaneously hypertensive rats

Clinical and Experimental Pharmacology and Physiology

Volumn 24, Issue 2, 1997, Pages 139-142

  Khan, Azharul Islam ^a   Kato, Johji ^a   Kitamura, Kazuo ^a   Kangawa, Kenji ^b   Eto, Tanenao ^a  

^a UNIVERSITY OF MIYAZAKI   (Japan)

^b NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

Adrenomedullin; Chronic infusion; Hypotensive effect; Plasma renin activity; Rat; Vasodilatation

Indexed keywords

ADRENOMEDULLIN; ALDOSTERONE; ANTIHYPERTENSIVE AGENT; PEPTIDE; RENIN; VASODILATOR AGENT;

ANIMAL EXPERIMENT; ARTICLE; ELECTROLYTE EXCRETION; HYPERTENSION; MALE; NONHUMAN; PLASMA RENIN ACTIVITY; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; SYSTOLIC BLOOD PRESSURE; ANIMAL; BLOOD; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; HUMAN; HYPOTENSION; INFUSION; INFUSION PUMP; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; WISTAR KYOTO RAT;

ADRENOMEDULLIN; ALDOSTERONE; ANIMALS; ANTIHYPERTENSIVE AGENTS; HUMANS; HYPOTENSION; INFUSION PUMPS, IMPLANTABLE; INFUSIONS, PARENTERAL; MALE; PEPTIDES; RATS; RATS, INBRED SHR; RATS, INBRED WKY; RENIN; RENIN-ANGIOTENSIN SYSTEM; VASODILATOR AGENTS;

EID: 0030615213     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1681.1997.tb01796.x     Document Type: Article

References (17)

1. Kitamura K, Kangawa K, Kawamoto M et al. Adrenomedullin: A novel hypotensive peptide isolated from human pheochromocytoma. Biochem. Biophys. Res. Commun. 1993; 192: 553-60.
2. Nuki C, Kawasaki H, Kitamura K et al. Vasodilator effect of adrenomedullin and calcitonin gene-related peptide receptors in rat mesenteric vascular beds. Biochem. Biophys. Res. Commun. 1993; 196: 245-51.
3. Ishiyama Y, Kitamura K, Ichiki Y et al. Hemodynamic effects of a novel hypotensive peptide, human adrenomedullin, in rats. Eur. J. Pharmacol. 1993; 241: 271-3.
4. Jougasaki M, Wei C, Aarhus LL, Heublein DM, Sandberg SM, Burnett JC. Renal localization and actions of adrenomedullin: A natriuretic peptide. Am. J. Physiol. 1995; 268: F657-63.
5. Ebara T, Miura K, Okumura M et al. Effect of adrenomedullin on renal hemodynamics and functions in dogs. Eur. J. Pharmacol. 1994; 263: 69-73.
6. Kitamura K, Ichiki Y, Tanaka M et al. Immunoreactive adrenomedullin in human plasma. FEBS. Lett. 1994; 341: 288-90.
7. Kato J, Kitamura K, Kuwasako K et al. Plasma adrenomedullin in patients with primary aldosteronism. Am. J. Hypertens. 1995; 8: 997-1000.
8. Ishiyama Y, Kitamura K, Ichiki Y et al. Hemodynamic responses to rat adrenomedullin in anaesthetized spontaneously hypertensive rats. Clin. Exp. Pharmacol. Physiol. 1995; 22: 614-18.
9. Ichiki Y, Kitamura K, Kangawa K, Kawamoto M, Matsuo H, Eto T. Distribution and characterization of immunoreactive adrenomedullin in human tissue and plasma. FEBS. Lett. 1994; 338: 6-10.
10. Ryan MJ, Hicks GW, Batley BL et al. Effect of an orally active renin inhibitor Cl-992 on blood pressure in normotensive and hypertensive monkeys. J. Pharmacol. Exp. Ther. 1994; 268: 372-9.
11. Shionoiri H, Minamizawa K, Sugimoto K et al. Fundamental and clinical studies on SPAC-S aldosterone RIA kit. J. Med. Pharm. Sci. 1989; 21: 293-302.
12. Sakata J, Shimokubo T, Kitamura K et al. Distribution and characterization of immunoreactive rat adrenomedullin in tissue and plasma. FEBS. Lett. 1994; 352: 105-8.
13. Ishizaka Y, Ishizaka Y, Tanaka M et al. Adrenomedullin stimulates cyclic AMP formation in rat vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 1994; 200: 642-6.
14. Itahara Y, Watanabe TX, Inui T, Chino N, Kimura T, Sakakibara S. Analysis of hypotensive mechanisms of human and rat adrenomedullin in anesthetized rat. Jpn. J. Pharmacol. 1994; 64 (Suppl. 1): 145.
15. Kato J, Kitamura K, Kangawa K, Eto T. Receptors for adrenomedullin in human vascular endothelial cells. Eur. J. Pharmacol. 1995; 289: 383-5.
16. Kato J, Kobayashi K, Etoh T et al. Plasma adrenomedullin concentration in patients with heart failure. J. Clin. Endocrinol. Metab. 1996; 81: 180-3.
17. Ishimitsu T, Nishikimi T, Saito Y et al. Plasma levels of adrenomedullin, a newly identified hypotensive peptide, in patients with hypertension and renal failure. J. Clin. Invest. 1994; 94: 2158-61.